An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)

Clinical trial NCT00496626 · COMPLETED

Trial details

NCT number: NCT00496626
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Papillomavirus Infections

Start date: 2008-07-20
Primary completion: 2009-02-28
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.